PE News & Analysis

Powered by the ListAlpha platform
Back to news

H.I.G. Capital Acquires ITH Group Limited in UK

9 June 2025
PR Newswire
H.I.G. Capital, a prominent global alternative investment firm managing $70 billion in capital, has acquired ITH Group Limited, a leading UK provider of aseptic pharmaceutical compounding services. The financial details of the acquisition remain undisclosed. This partnership includes ITH's founders, Adam Bloom and Karen Hamling, who will continue to lead the company.

ITH specializes in preparing customized injectable medications for patients with unique medical needs, particularly in areas where existing treatments fall short. The company is recognized for its expertise in chemotherapy, total parenteral nutrition, and central intravenous additive services, catering to both adult and neonatal patients. Additionally, ITH operates a digital pharmacy that supplies essential licensed medications to private and NHS patients.

H.I.G. plans to support ITH's ongoing growth and enhance its production capacity. The existing management team will remain intact, ensuring continuity in leadership as they pursue new initiatives.

Adam Bloom, CEO of ITH, expressed enthusiasm about H.I.G.'s investment, highlighting the company's commitment to growth since its inception in 2008. He emphasized ITH's dedication to expanding its service offerings and advancing its capabilities in providing critical compounded medicines.

John Harper, Managing Director at H.I.G., praised ITH's reliable service in an undersupplied market and expressed excitement about the potential for further growth. He noted that H.I.G.'s experience in supporting capacity expansion aligns well with ITH's objectives.

Gordon Cameron, non-executive Chairman of ITH, commended the impressive business built by Bloom and Hamling, recognizing its critical role in the UK health sector. He looks forward to contributing to the company's next growth phase as part of H.I.G.'s investment.

Founded in 2008, ITH operates from London and focuses on aseptic compounding services for both NHS and private clients. The company has established a strong reputation for reliability and high-quality customer service.

H.I.G. Capital, established in 1993, has invested in over 400 companies globally, with a current portfolio of more than 100 companies generating combined sales exceeding $53 billion. The firm specializes in providing both debt and equity capital to middle-market companies, employing a flexible, operationally focused approach. H.I.G. also manages a publicly traded business development company and has real estate and infrastructure investment funds.

For more information about ITH Group, visit their website at ithgroup.uk, and for details about H.I.G. Capital, refer to hig.com.
Tags
Companies
Keywords
healthcare
pharmaceuticals
aseptic compounding
Industry
Strategy
Geography

Request a demo of ListAlpha

We tailor your onboarding experience to match what you're looking for. Tell us more about yourself and your team to help us out.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DenyAccept All